All instruments
Mercury Laboratories Limited
- Stock
- 538964
- BSE
- ₹750.00−6.01%
- Delayed close, 06 Nov
Details
- INE947G01011
- Healthcare
- Pharmaceuticals
- Face value ₹10
- Market cap ≈ ₹90 Cr (est.)
Paid for 10 years without a break
Dividend per share by FY
Split-adjusted · FY 2026–27 to date · last 7 of 11 years · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY 2015–16 | ₹1.50 |
| FY 2017–18 | ₹1.50 |
| FY 2018–19 | ₹1.50 |
| FY 2019–20 | ₹1.50 |
| FY 2020–21 | ₹3.50 |
| FY 2021–22 | ₹2.00 |
| FY 2022–23 | ₹3.50 |
| FY 2023–24 | ₹3.50 |
| FY 2024–25 | ₹3.50 |
| FY 2025–26 | ₹3.50 |
| FY 2026–27 | ₹3.50 |
TTM payout
₹3.50
1 payout in 12 months
Yield
0.47%
Dividend yield · trailing 12 months
52-wk closing range ₹700.00 – ₹888.45
Yield and payout totals recalculated 07 Nov 2026.
Recent payouts
· 12 on record since FY 2015–16| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 21 Sep 2026 | Final | same day | ₹3.50 |
| 06 Aug 2025 | Final | same day | ₹3.50 |
| 20 Sep 2024 | Final | — | ₹3.50 |
| 20 Sep 2023 | Final | — | ₹3.50 |
| 19 Sep 2022 | Final | — | ₹3.50 |
Income calculator
₹466
Expected income per year, before tax, at the current 0.47% yield
≈ 133 shares at ₹750.00, using ₹99,750 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.